{
  "created_at": "2018-08-03T21:00:01.000Z",
  "updated_at": "2021-01-06T08:24:30.854Z",
  "id": "ef6f6a1e-e96f-4af2-a68e-d547f7c1f4b8",
  "labels": "current-affairs,2018-08-04",
  "question": "Recently, the drugmaker Cipla has received regulatory approval in India to sell its version of “Truvada”, which when given to healthy people reduces the risk of getting affected by _?",
  "option1": "Typhoid",
  "option2": "HIV/AIDS",
  "option3": "Hepatitis B",
  "option4": "Tuberculosis",
  "option5": "",
  "answer": "HIV/AIDS",
  "explanation": "The drug called Truvada has been approved for the treatment of HIV in infected patients. It works by lowering the amount of virus circulating in people’s blood. Also the recent clinical trials show that it can also protect uninfected high-risk people from acquiring the virus, if they take the drug daily before and after exposure. Truvada contains the active substances emtricitabine and tenofovir disoproxil fumarate. Drugmaker Cipla has received regulatory approval in India to sell its version of Truvada."
}